Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference18 articles.
1. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2);Serle;Am J Ophthalmol,2018
2. Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2);Kahook;Am J Ophthalmol,2019
3. Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study;Khouri;Am J Ophthalmol,2019
4. Emerging trabecular outflow drugs;Kopczynski;J Ocul Pharmacol Ther,2014
5. Netarsudil increases outflow facility in human eyes through multiple mechanisms;Ren;Invest Ophthalmol Vis Sci,2016
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Crystalline keratopathy following long-term netarsudil therapy;American Journal of Ophthalmology Case Reports;2024-09
2. The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study;Ophthalmology and Therapy;2024-04-30
3. Reticular Bullous Epithelial Corneal Edema after Netarsudil Use for Elevated Intraocular Pressure with Concurrent Fuchs Endothelial Corneal Dystrophy: A Case Report;Case Reports in Ophthalmology;2024-04-17
4. Reticular epithelial corneal oedema secondary to topical netarsudil drops;The National Medical Journal of India;2024-03-11
5. In vivo confocal microscopy findings after Descemet stripping only with and without topical ripasudil supplementation in Fuchs endothelial dystrophy;Canadian Journal of Ophthalmology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3